Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab, Nps Pharma IncfiledCriticalAstrazeneca Ab
Publication of TW200602041ApublicationCriticalpatent/TW200602041A/en
The present invention relates to new compounds of formula I, to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
TW094104635A2004-02-182005-02-17Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
TW200602041A
(en)